查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130685

攜帶式透析機市場分析及預測（至2035年）：類型、產品、技術、組件、應用、最終用戶、功能、安裝類型、設備、模式

Portable Dialysis Devices Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, End User, Functionality, Installation Type, Equipment, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球攜帶式透析機市場預計將從2025年的5.185億美元成長到2035年的8.445億美元，複合年成長率（CAGR）為5.0%。這項需求成長的驅動力是日益嚴重的腎臟疾病負擔。美國疾病管制與預防中心（CDC）在2026年報告稱，美國預計將有3700萬成年人（佔總人口的14%）患有慢性腎臟病。該機構最新的公共衛生數據顯示，每天約有360人開始接受腎衰竭治療。世界衛生組織（WHO）估計，2010年全球有260萬人接受了透析或腎臟移植治療，並預測2030年這項需求可能達到540萬人。此外，美國食品藥物管理局（FDA）的記錄顯示，家用透析系統監管活動持續進行，包括NxStage和Tablo的獲批，以及小型化、連網化和家庭透析設備的持續技術研發。這些趨勢進一步增強了目標市場的機會。

在整體產品格局中，透析機構成核心治療平台，並輔以透析器、濃縮液和溶液、血液迴路以及導管，共同實現體外血液淨化。攜帶式透析設備優先考慮面積小、整合安全控制、降低水耗和能耗以及便攜性。同時，透析器決定溶質清除率和超過濾性能。濃縮液和溶液維持預設的電解質平衡，而血液迴路和導管則負責液體循環和血管連接。市場對緊湊、一次性使用和簡化的組件的需求日益成長，以降低安裝複雜性和物流負擔。預計產品創新將集中於整合式濾芯、遠端監控、生物相容性以及提升家用和分散式透析系統的便攜性。

市場區隔
類型 血液透析、腹膜透析、穿戴式透析設備等。
產品 攜帶式血液透析機、攜帶式腹膜透析機、穿戴式人工腎臟等。
科技 持續性攜帶式腹膜透析（CAPD）、自動腹膜透析（APD）、常規血液透析、夜間血液透析等。
成分 透析器、血液迴路、濃縮液、導管及其他設備。
目的 居家醫療、門診護理、醫院及其他
最終用戶 病患、醫護人員、透析中心及其他人員
功能 一次性、可重複使用或其他
安裝類型 攜帶式、穿戴式式及其他
裝置 透析機、水處理系統及其他
模式 連續的、間歇的以及其他

從功能上看，根據對治療控制和工作流程的支持程度，系統可分為自動化系統和手動系統。自動化設備整合了可程式設計超過濾、血流管理、壓力監測、警報、治療順序等功能，並且在某些配置中還具備遠端臨床監測連接功能。這些功能提高了治療的可重複性，減輕了操作人員的負擔，並支持居家照護。手動系統則需要臨床醫生或受過訓練的使用者在設定、參數調整、監測和故障排除方面進行更多干預，但其配置更簡單，技術複雜度也更低。隨著醫療機構對標準化治療、患者便利性、安全性和遠端監測的需求日益成長，自動化系統的應用預計將成為主流，但當基礎設施、培訓或成本限制影響採購決策時，手動功能仍將發揮重要作用。

區域概覽

北美憑藉其完善的透析基礎設施、較高的腎衰竭診斷率、成熟的健保報銷體系和成熟的醫療設備生態系統，維持著強勁的市場地位。美國擁有龐大的患者群體，根據美國疾病管制與預防中心（CDC）的數據估計，到2026年，將有3,700萬成年人（佔成年人口的14%）患有慢性腎臟病。美國食品藥物管理局（FDA）對家用血液透析系統的分類和批准，顯示分散式治療技術已建立一套完善的監管路徑。領先的透析服務提供者、醫療設備製造商、專科診所和居家照護網路為產品開發、培訓和售後服務提供支援。強調家用透析、以價值為導向的醫療保健以及減少對治療場所依賴的政策，將繼續推動攜帶式醫療設備在全部區域的普及。

亞太地區擁有巨大的成長潛力，這得益於人口稠密市場透析服務的普及、醫療基礎設施的改善以及慢性病盛行率的上升。腎臟護理能力的提升、醫院的現代化、本地醫療設備製造以及對居家醫療的投資，正為行動科技在主要都市區以外的廣泛應用鋪平道路。儘管日本和澳洲的居家照護體系相對成熟，但中國、印度和東南亞市場仍存在大量未接受治療或服務不足的患者群體，且私人醫療網路正在不斷擴張。製造商正日益關注小型化系統、在地化供應鏈以及適應不同資源條件環境的培訓模式。從長遠來看，完善的保險報銷體系、醫護人員意識的提高、互聯互通的增強以及分散式醫療政策有望加速攜帶式透析技術的普及。

主要趨勢和促進因素

攜帶式透析進入「互聯照護」時代：

市場正朝著互聯、易用且日益自動化的攜帶式透析平台發展，這些平台將緊湊的硬體與遠端監控和數位化治療管理相結合。獲得FDA批准的技術展現了連接性、治療數據傳輸和整合式家庭使用功能，從而能夠在傳統透析中心之外實現更全面的臨床監管。這種轉變促使製造商優先考慮縮小面積、簡化工作流程、整合安全系統、無線資料交換和以患者為中心的介面。更廣泛的去中心化醫療模式的轉變，推動了對能夠支持靈活治療環境並同時保持臨床管理和治療一致性的設備的需求。

腎臟疾病負擔日益加重，推動了對攜帶式透析的需求。

隨著慢性腎臟病和腎衰竭盛行率的上升，需要長期腎臟替代治療的人也不斷擴大。根據美國疾病管制與預防中心（CDC）的數據顯示，預計到2026年，美國成年人中將有14%患有慢性腎臟病，每天約有360人開始接受腎衰竭治療。透析需求為傳統醫療機構帶來了沉重負擔，而可攜式系統提供了一種居家和分散式治療方案，提高了預約的柔軟性，並減少了對專用醫療機構基礎設施的依賴。居家透析在臨床上的日益普及、自動化技術的進步以及對遠端患者監護的投資，都進一步增強了攜帶式設備的商業性合理性。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 血液透析
    • 腹膜透析
    • 穿戴式透析設備
    • 其他
  • 市場規模及預測：依產品分類
    • 攜帶式血液透析機
    • 攜帶式腹膜透析機
    • 穿戴式人工腎臟
    • 其他
  • 市場規模及預測：依技術分類
    • 持續性攜帶式腹膜透析（CAPD）
    • 自動腹膜透析（APD）
    • 傳統血液透析
    • 夜間血液透析
    • 其他
  • 市場規模及預測：依組件分類
    • 透析器
    • 血液循環
    • 集中
    • 導管
    • 其他
  • 市場規模及預測：依應用領域分類
    • 居家醫療
    • 門診醫療服務
    • 醫院
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 病人
    • 醫療服務提供方
    • 透析中心
    • 其他
  • 市場規模及預測：依功能分類
    • 一次使用
    • 可重複使用的
    • 其他
  • 市場規模及預測：依安裝類型分類
    • 可攜式的
    • 穿戴式裝置
    • 其他
  • 市場規模及預測：依設備分類
    • 透析機
    • 水處理系統
    • 其他
  • 市場規模及預測：按模式
    • 連續型
    • 間歇性的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Fresenius Medical Care
  • Baxter International
  • DaVita Inc
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Asahi Kasei Corporation
  • NxStage Medical
  • Quanta Dialysis Technologies
  • AWAK Technologies
  • Outset Medical
  • Diality Inc
  • Medtronic
  • JMS Co Ltd
  • Toray Medical Co Ltd
  • Kawasumi Laboratories
  • Medica SpA
  • Rockwell Medical
  • Infomed SA
  • SWS Hemodialysis Care Co Ltd
  • Medionics International Inc

第9章 關於我們

簡介目錄
Product Code: GIS11053

The global Portable Dialysis Devices Market is projected to grow from $518.5 Million in 2025 to $844.5 Million by 2035, at a compound annual growth rate (CAGR) of 5.0%. Demand is supported by a substantial and expanding renal disease burden. The CDC reported in 2026 that 37 million U.S. adults, or 14%, were estimated to have chronic kidney disease, while its latest public-health data indicate that about 360 people begin kidney-failure treatment each day. WHO estimates that 2.6 million people received dialysis or transplantation globally in 2010 and projects this requirement could reach 5.4 million by 2030. FDA records also show continued regulatory activity for home-use systems, including NxStage and Tablo clearances, indicating sustained technology development toward compact, connected, and home-oriented dialysis delivery. These trends strengthen the addressable opportunity.

The product landscape includes dialysis machines as the core treatment platform, supported by dialyzers, concentrates and solutions, bloodlines, and catheters that collectively enable extracorporeal blood purification. Portable machines prioritize reduced footprint, integrated safety controls, lower water and power requirements, and transportability, while dialyzers determine solute clearance and ultrafiltration performance. Concentrates and solutions maintain prescribed electrolyte balance, whereas bloodlines and catheters provide fluid and vascular connectivity. Demand increasingly favors compact, disposable, and simplified components that reduce setup complexity and logistics burdens. Product innovation is expected to emphasize integrated cartridges, remote monitoring, biocompatibility, and improved portability for home and decentralized dialysis systems.

Market Segmentation
TypeHemodialysis, Peritoneal Dialysis, Wearable Dialysis Devices, Others
ProductPortable Hemodialysis Machines, Portable Peritoneal Dialysis Machines, Wearable Artificial Kidney, Others
TechnologyContinuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD), Conventional Hemodialysis, Nocturnal Hemodialysis, Others
ComponentDialyzers, Bloodlines, Concentrates, Catheters, Others
ApplicationHome Care Settings, Ambulatory Services, Hospitals, Others
End UserPatients, Healthcare Providers, Dialysis Centers, Others
FunctionalitySingle-Use, Reusable, Others
Installation TypePortable, Wearable, Others
EquipmentDialysis Machines, Water Treatment Systems, Others
ModeContinuous, Intermittent, Others

Functionality is divided into automated and manual systems according to treatment control and workflow assistance. Automated devices integrate programmable ultrafiltration, blood-flow management, pressure monitoring, alarms, treatment sequencing, and, in some configurations, connectivity for remote clinical oversight. These features improve reproducibility, reduce operator burden, and support home-based care. Manual systems require greater clinician or trained-user intervention for setup, parameter adjustment, monitoring, and troubleshooting, but can offer simpler architectures and lower technological complexity. Adoption is expected to favor automation as providers seek standardized treatment, patient convenience, safety, and remote supervision, although manual functionality remains relevant where infrastructure, training, or affordability constraints influence procurement decisions.

Geographical Overview

North America maintains a strong position because of extensive dialysis infrastructure, high diagnosed kidney-failure prevalence, established reimbursement mechanisms, and a mature medical-device ecosystem. The United States provides a substantial patient base, with CDC data showing 37 million adults, or 14% of adults, estimated to have chronic kidney disease in 2026. FDA classifications and clearances for home-use hemodialysis systems demonstrate an established regulatory pathway for decentralized treatment technologies. Leading dialysis providers, device manufacturers, specialty clinics, and home-care networks support commercialization, training, and servicing. Policy emphasis on home dialysis, value-based care, and reducing treatment-site dependence should continue supporting portable-device adoption across the region.

Asia-Pacific presents substantial expansion potential as dialysis access broadens, healthcare infrastructure develops, and chronic disease prevalence increases across populous markets. Investments in renal-care capacity, hospital modernization, local medical-device manufacturing, and home healthcare are creating pathways for portable technologies beyond major urban centers. Japan and Australia provide relatively mature home-care environments, while China, India, and Southeast Asian markets offer large untreated or underserved patient pools and expanding private healthcare networks. Manufacturers are increasingly targeting compact systems, localized supply chains, and training models suited to resource-variable settings. Over the longer term, improving reimbursement, clinician awareness, connectivity, and decentralized-care policies should accelerate adoption.

Key Trends and Drivers

Portable Dialysis Enters the Connected-Care Era:

The market is moving toward connected, user-friendly, and increasingly automated portable dialysis platforms that combine compact hardware with remote monitoring and digital treatment management. FDA-cleared technologies demonstrate the integration of connectivity, treatment-data transmission, and home-use functionality, supporting greater clinical oversight outside traditional dialysis facilities. This transition is encouraging manufacturers to prioritize smaller footprints, simplified workflows, integrated safety systems, wireless data exchange, and patient-centric interfaces. The broader shift toward decentralized care is strengthening demand for devices capable of supporting flexible treatment environments while maintaining clinical control and treatment consistency.

Rising Kidney Disease Burden Fuels Portable Dialysis Demand:

The increasing prevalence of chronic kidney disease and kidney failure is expanding the underlying patient population requiring long-term renal replacement therapy. CDC data indicate that 14% of U.S. adults were estimated to have chronic kidney disease in 2026, while approximately 360 people begin kidney-failure treatment each day. As dialysis demand places pressure on conventional centers, portable systems provide an avenue for home-based and decentralized treatment, potentially improving scheduling flexibility and reducing dependence on dedicated facility infrastructure. Growing clinical acceptance of home dialysis, technological improvements in automation, and investments in remote patient monitoring further reinforce the commercial rationale for portable device adoption.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Hemodialysis
    • 4.1.2 Peritoneal Dialysis
    • 4.1.3 Wearable Dialysis Devices
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Portable Hemodialysis Machines
    • 4.2.2 Portable Peritoneal Dialysis Machines
    • 4.2.3 Wearable Artificial Kidney
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • 4.3.2 Automated Peritoneal Dialysis (APD)
    • 4.3.3 Conventional Hemodialysis
    • 4.3.4 Nocturnal Hemodialysis
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Dialyzers
    • 4.4.2 Bloodlines
    • 4.4.3 Concentrates
    • 4.4.4 Catheters
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Home Care Settings
    • 4.5.2 Ambulatory Services
    • 4.5.3 Hospitals
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Patients
    • 4.6.2 Healthcare Providers
    • 4.6.3 Dialysis Centers
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Single-Use
    • 4.7.2 Reusable
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 Portable
    • 4.8.2 Wearable
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Dialysis Machines
    • 4.9.2 Water Treatment Systems
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Continuous
    • 4.10.2 Intermittent
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Equipment
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Equipment
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Equipment
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Equipment
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Equipment
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Equipment
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Equipment
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Equipment
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Equipment
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Equipment
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Equipment
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Equipment
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Equipment
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Equipment
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Equipment
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Equipment
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Equipment
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Equipment
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Equipment
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Equipment
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Equipment
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Equipment
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Equipment
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Equipment
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Fresenius Medical Care
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Baxter International
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 DaVita Inc
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Nipro Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 B. Braun Melsungen AG
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Asahi Kasei Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 NxStage Medical
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Quanta Dialysis Technologies
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 AWAK Technologies
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Outset Medical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Diality Inc
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Medtronic
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 JMS Co Ltd
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Toray Medical Co Ltd
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Kawasumi Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Medica SpA
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Rockwell Medical
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Infomed SA
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 SWS Hemodialysis Care Co Ltd
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Medionics International Inc
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us